Cost Variation Analysis Of Various Antifungal Drugs Available In The Indian Market.

Research Journal of Pharmaceutical, Biological and Chemical Sciences

article

Srinjoy B¹  K Girish¹  Jyothi R.² 

[1] Dept of Pharmacology, Kempegowda Institute of Medical Sciences;Department of Pharmacology, Kempegowda Institute of Medical Sciences

关键词: Pharmacoeconomics;    Antifungal Drugs;    Cost ratio;    Percentage cost variation;   

DOI  :  10.33887/rjpbcs/2023.14.1.12

学科分类：工程和技术（综合）

来源: Research Journal of Pharmaceutical, Biological and Chemical Sciences

【 摘 要 】

Treating fungal infections are generally long-term and expensive. High medical care cost should benoted by policy makers and healthcare providers to reduce the economic burden from patients. This was across sectional study conducted to analyze the cost variation of antifungal drugs available in differentformulations in our Indian market. The information on cost of each drug with its dosage and formulationwas obtained from “Current index of medical specialties” (CIMS) April-July 2022 India, Indian Drug Reviewth 28 year 2022 Issue 3 and Jan Aushadhi price list 2022 scheme. Cost ratio and percentage cost of drugsavailable in Indian market under different brand names manufactured by different pharmaceuticalindustries were calculated. Results:Highest cost ratio was observed with itraconazole 200mg Cap (30.6)and lowest with Caspofungin 70mg Inj (1.05). Percentage cost variation was maximum with itraconazole200mg Cap for 1 tablet (2960%) and minimum with Caspofungin 70mg Inj (5.92%) for 1 tablet. Antifungaltreatment is generally long term and it requires patient compliance and strict adherence to therapy. Sincethere is wide cost variation among antifungal agents available in Indian Market, cost policy regulation andsensitizing the physician for selecting the appropriate brand of drugs is required.

【 授权许可】

All Rights reserved